Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FC Franklin Covey	$18.87 -0.9%	$21.36	$18.40 ▼ $44.16	$238.30M	0.91	128,688 shs	79,181 shs
LGC Legacy Acquisition		$9.92	$7.62 ▼ $11.36	N/A	N/A	96,452 shs	4,153 shs
MAX MediaAlpha	$10.95 -3.9%	$10.59	$7.33 ▼ $20.91	$733.98M	1.19	431,637 shs	737,870 shs
NEO NeoGenomics	$5.80 +0.7%	$6.82	$4.72 ▼ $19.11	$749.24M	1.54	2.98 million shs	1.84 million shs

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FC Franklin Covey	0.00%	+1.24%	-9.58%	-10.65%	-50.78%
LGC Legacy Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
MAX MediaAlpha	0.00%	+11.28%	+2.15%	+9.17%	-31.35%
NEO NeoGenomics	0.00%	+12.40%	-22.56%	-27.95%	-63.41%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FC Franklin Covey	3.8865 of 5 stars	3.5	2.0	0.0	0.0	2.8	2.5	3.1
LGC Legacy Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	3.4168 of 5 stars	3.5	3.0	0.0	0.0	2.0	2.5	1.9
NEO NeoGenomics	4.2703 of 5 stars	4.2	5.0	0.0	0.0	2.9	3.3	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FC Franklin Covey	3.00	Buy	$31.00	64.27% Upside
LGC Legacy Acquisition	0.00	N/A	N/A	N/A
MAX MediaAlpha	3.00	Buy	$17.92	63.62% Upside
NEO NeoGenomics	2.33	Hold	$12.75	119.83% Upside

Current Analyst Ratings Breakdown

Latest LGC, NEO, FC, and MAX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/4/2025	NEO NeoGenomics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$12.00 ➝ $11.00
7/30/2025	NEO NeoGenomics	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$10.00 ➝ $8.00
7/30/2025	NEO NeoGenomics	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
7/29/2025	NEO NeoGenomics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.50 ➝ $8.00
7/29/2025	NEO NeoGenomics	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Market Perform
7/7/2025	FC Franklin Covey	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$30.00 ➝ $27.00
7/3/2025	FC Franklin Covey	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$35.00
5/15/2025	NEO NeoGenomics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral

(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FC Franklin Covey	$287.23M	0.83	$2.71 per share	6.96	$6.35 per share	2.97
LGC Legacy Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	$864.70M	0.85	$0.36 per share	30.53	($0.69) per share	-15.87
NEO NeoGenomics	$660.57M	1.13	$0.44 per share	13.22	$7.03 per share	0.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FC Franklin Covey	$23.40M	$0.79	23.89	13.98	1.52	3.81%	19.08%	6.12%	N/A
LGC Legacy Acquisition	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	$16.63M	-$0.12	N/A	12.73	N/A	-0.61%	-62.53%	12.91%	10/29/2025 (Estimated)
NEO NeoGenomics	-$78.73M	-$0.81	N/A	64.44	N/A	-15.10%	-2.72%	-1.54%	N/A

Latest LGC, NEO, FC, and MAX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/6/2025	Q2 2025	MAX MediaAlpha	$0.16	$0.17	+$0.01	-$0.33	$248.80 million	$251.62 million
7/2/2025	Q3 2025	FC Franklin Covey	-$0.08	$0.18	+$0.26	-$0.11	$67.49 million	$67.12 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FC Franklin Covey	N/A	N/A	N/A	N/A	N/A
LGC Legacy Acquisition	N/A	N/A	N/A	N/A	N/A
MAX MediaAlpha	N/A	N/A	N/A	N/A	N/A
NEO NeoGenomics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FC Franklin Covey	0.02	0.84	0.81
LGC Legacy Acquisition	N/A	N/A	N/A
MAX MediaAlpha	N/A	1.29	1.29
NEO NeoGenomics	0.40	3.92	3.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
FC Franklin Covey	69.88%
LGC Legacy Acquisition	N/A
MAX MediaAlpha	64.39%
NEO NeoGenomics	98.50%

Insider Ownership

Company	Insider Ownership
FC Franklin Covey	15.50%
LGC Legacy Acquisition	N/A
MAX MediaAlpha	11.53%
NEO NeoGenomics	2.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
FC Franklin Covey	1,084	12.64 million	10.68 million	Optionable
LGC Legacy Acquisition	N/A	N/A	N/A	Not Optionable
MAX MediaAlpha	160	67.03 million	59.30 million	Not Optionable
NEO NeoGenomics	2,200	129.18 million	126.08 million	Optionable

LGC, NEO, FC, and MAX Headlines

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO

August 9 at 11:35 AM | globenewswire.com

Why NeoGenomics (NEO) Stock Is Trading Up Today

August 8 at 6:47 AM | finance.yahoo.com

NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Recommendation of "Hold" from Brokerages

August 7 at 4:09 AM | marketbeat.com

Piper Sandler Reiterates $11.00 Price Target for NeoGenomics (NASDAQ:NEO)

August 7 at 2:53 AM | americanbankingnews.com

NeoGenomics (NEO) Gets a Buy from Piper Sandler

August 6, 2025 | theglobeandmail.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

August 6, 2025 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

August 6, 2025 | prnewswire.com

NeoGenomics (NEO) Targets Opportunity at $5 billion Liquid Biopsy Market

August 5, 2025 | msn.com

NeoGenomics (NASDAQ:NEO) Given New $11.00 Price Target at Piper Sandler

August 5, 2025 | marketbeat.com

NeoGenomics (NASDAQ:NEO) Sets New 12-Month Low - Here's Why

August 5, 2025 | marketbeat.com

NeoGenomics, Inc. (NASDAQ:NEO) Shares Sold by TD Asset Management Inc

August 5, 2025 | marketbeat.com

Universal Beteiligungs und Servicegesellschaft mbH Invests $1.09 Million in NeoGenomics, Inc. (NASDAQ:NEO)

August 3, 2025 | marketbeat.com

NeoGenomics (NASDAQ:NEO) Shares Up 7.3% - Here's Why

August 2, 2025 | marketbeat.com

NeoGenomics Earnings Call: Growth Amid Challenges

August 2, 2025 | theglobeandmail.com

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and TNL Mediagene (TNMG)

August 1, 2025 | theglobeandmail.com

NeoGenomics (NEO) was downgraded to a Hold Rating at BTIG

August 1, 2025 | theglobeandmail.com

NeoGenomics (NASDAQ:NEO) Given a $8.00 Price Target at Morgan Stanley

August 1, 2025 | americanbankingnews.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. - NEO

July 31, 2025 | prnewswire.com

NeoGenomics (NASDAQ:NEO) Sees Strong Trading Volume - Should You Buy?

July 31, 2025 | marketbeat.com

NeoGenomics (NASDAQ:NEO) Price Target Lowered to $8.00 at Morgan Stanley

July 31, 2025 | marketbeat.com

Needham & Company LLC Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock Price

July 31, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why the American Eagle Stock Rally Isn't Just Speculation
By Gabriel Osorio-Mazilli | July 28, 2025
View Why the American Eagle Stock Rally Isn't Just Speculation
3 Short Squeeze Candidates With Big Catalysts on the Horizon
By Dan Schmidt | July 25, 2025
View 3 Short Squeeze Candidates With Big Catalysts on the Horizon
This Drone Stock Is on Sale Despite Big Army Contract
By Jeffrey Neal Johnson | July 31, 2025
View This Drone Stock Is on Sale Despite Big Army Contract
3 Stocks Offering Diversification in Trump’s Tariff & Trade Reset
By Chris Markoch | July 21, 2025
View 3 Stocks Offering Diversification in Trump’s Tariff & Trade Reset
Why Freeport-McMoRan Stock May Hit a New High After Earnings Beat
By Chris Markoch | July 25, 2025
View Why Freeport-McMoRan Stock May Hit a New High After Earnings Beat

LGC, NEO, FC, and MAX Company Descriptions

Franklin Covey NYSE:FC

$18.87 -0.18 (-0.94%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$18.84 -0.03 (-0.16%)

As of 08/8/2025 05:46 PM Eastern

Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.

Legacy Acquisition NYSE:LGC

Legacy Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2016 and is based in Cincinnati, Ohio.

MediaAlpha NYSE:MAX

$10.95 -0.44 (-3.86%)

Closing price 08/8/2025 03:59 PM Eastern

Extended Trading

$10.86 -0.09 (-0.87%)

As of 08/8/2025 06:03 PM Eastern

MediaAlpha, Inc., through its subsidiaries, operates an insurance customer acquisition platform in the United States. It optimizes customer acquisition in various verticals of property and casualty insurance, health insurance, and life insurance. The company was founded in 2014 and is headquartered in Los Angeles, California.

NeoGenomics NASDAQ:NEO

$5.80 +0.04 (+0.69%)

Closing price 08/8/2025 04:00 PM Eastern

Extended Trading

$5.74 -0.06 (-1.03%)

As of 08/8/2025 05:06 PM Eastern

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time